AXP raised its quarterly dividend 16% to $0.95 per share, equal to about a 1.1% forward dividend yield at the current price.

AXP returned $2.3 billion to shareholders in Q1 2026, comprising about $1.66 billion of share buybacks and $652 million of dividends.

Management reaffirmed full-year 2026 guidance of 9–10% revenue growth and EPS of $17.30–$17.90, supported by billed business of $428.0 billion (+10%), the strongest quarterly spend growth in three years.

The average 12-month price target clusters around $363–$365 (MarketBeat $365.05), implying only ~8% upside from $338.15, with a target range spanning roughly $285–$295 on the low end to $415–$450 on the high end across aggregators.

Recent 90-day actions skew positive: DZ Bank upgraded AXP to Buy from Hold at $375 (June 18, 2026), Truist raised its target to $375 from $360 with a Buy (June 24), Piper Sandler initiated Overweight at $396 (June 29), and Loop Capital initiated Buy at $389 (May 21).

AXP beat in Q1 2026 with diluted EPS of $4.28 (+18% YoY) versus ~$4.02 consensus and revenue of $18.9B (+11% YoY) versus ~$18.6B, driven by ~10% card-member spend growth rather than one-time items.

Management reaffirmed rather than raised FY2026 guidance (revenue growth 9–10%, EPS $17.30–$17.90) alongside higher marketing/tech spend, and the stock fell ~3.5% to about $318.55 on April 23, 2026 in response — an execution/expectations risk.

In Q1 2026 (reported April 23, 2026), American Express posted total revenues net of interest expense of $18.9 billion (up 11% YoY) and diluted EPS of $4.28 (up 18% YoY), with net income of $2.97 billion versus $2.58 billion a year earlier.

Despite the Q1 2026 beat, AXP shares fell about 3.5% on April 23, 2026 because management reaffirmed rather than raised full-year guidance (revenue growth of 9-10% and EPS of $17.30-$17.90) and signaled heavier reinvestment spending.

Q1 2026 credit metrics remained stable but showed modest deterioration: 30-day delinquency rates held at 1.4% (U.S. consumer) and 1.7% (U.S. small business), while net write-off rates edged up to 2.0% (consumer) and 2.8% (small business) on a principal-only basis.

AXP trades at a trailing P/E of roughly 20–21x and, against management's $17.30–$17.90 FY2026 EPS guidance, an implied forward P/E of about 19x — near the upper end of its recent multiple range.

The most-ranked risks are: (1) decelerating revenue/billed-business growth in US consumer and international card services if spending or travel slows; (2) elevated valuation (~20–21x trailing, top of range) leaving little margin for error; (3) rising card competition and slower commercial new-account growth; against a 'Buy' consensus with a $357.33 average target (range $285 BTIG to $415 Wells Fargo).

As of June 30, 2026, AXP traded at $338.15 and carried an overall 'Hold' consensus, with the MarketBeat panel splitting 1 Strong Buy, 11 Buy, 12 Hold, and 1 Sell.

Versus peer Capital One (COF, ~$200.62, ~$123.6B market cap), AXP trades at a premium on forward earnings — ~19x forward P/E vs COF's ~9.7x — while COF's 46.7x trailing P/E is distorted by its Discover acquisition rather than reflecting normalized earnings.

The most bearish current call is BTIG's $285 target (June 16, 2026), which implies roughly -16% downside from the $338 price and anchors the low end of the range on valuation and consumer-credit concerns.

At ~$338 and trailing EPS near $16.06, AXP trades around a 21x P/E, a modest premium to its ~19.7x three-year average, leaving limited valuation margin of safety versus its own history.

Ranked by potential downside, the leading red flags are: (1) consumer-credit/macro sensitivity given AXP's lend-and-spend model, (2) full valuation with only ~8% average upside and a -16% bear case, and (3) margin pressure from rising marketing/tech spend against reaffirmed (not raised) guidance.

AXP's year-to-date total return in 2026 is approximately -13.89%, leaving the stock roughly 12-13% below its 52-week high of $387.49 and about 6-7% above its 52-week low of $288.34.

As of late June 2026, AXP trades in a roughly $303-$325 one-month band (near ~$305-$311), below its 200-day moving average (cited between ~$297.54 and $324.99 across sources) and its 50-day average, with RSI(14) around 45 (neutral, slightly weak).

Technical support sits near the recent-range low of ~$303 and the 52-week low of $288.34, while resistance sits near the recent-range high of ~$325 and then the 52-week high of $387.49.

Wall Street's consensus on AXP is 'Buy' (roughly 28 buy, 16 hold, 3 sell) with an average 12-month price target of about $359-$365, implying only modest upside from current levels.

The most material risks, ranked by potential harm, are: (1) rising consumer credit stress given AXP's spend-and-lend model, (2) intensifying premium-card competition and decelerating revenue growth in U.S. consumer and international segments, (3) regulatory uncertainty, and (4) execution risk on elevated reinvestment spending, with concentration in affluent/premium-fee customers amplifying cyclicality.